Randall Children's Hospital is the children's hospital at Legacy Emanuel Medical Center in Portland in the U.S. state of Oregon. Formerly Legacy Emanuel Children's Hospital, it was renamed in 2011 during construction of the new 165-bed patient tower.

There are 165 beds in Legacy Emanuel Children's Hospital.

During the past decade, Legacy Emanuel Children's Hospital conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 53 clinical trials were completed, i.e. on average, 84.1% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 28 clinical trials were completed. i.e. 127.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Legacy Emanuel Children's Hospital" #1 sponsor was "Children's Oncology Group" with 69 trials, followed by "National Cancer Institute (NCI)" with 44 trials sponsored, "Pfizer" with 4 trials sponsored, "Wake Forest University Health Sciences" with 3 trials sponsored and "Abbott Nutrition" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Legacy Emanuel Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 71 trials as a collaborator, "Children's Oncology Group" with 6 trials as a collaborator, "Beat NB Cancer Foundation" with 2 trials as a collaborator, "Boston Children's Hospital" with 2 trials as a collaborator and "Childhood Arthritis and Rheumatology Research Alliance" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Legacy Emanuel Children's Hospital" are "Recurrent Neuroblastoma" (19 trials), "Recurrent Osteosarcoma" (14 trials), "Refractory Neuroblastoma" (14 trials), "Refractory Non-Hodgkin Lymphoma" (14 trials) and "Recurrent Hepatoblastoma" (12 trials). Many other conditions were trialed in "Legacy Emanuel Children's Hospital" in a lesser frequency.

Most popular intervention types in "Legacy Emanuel Children's Hospital" are "Drug" (98 trials), "Other" (84 trials), "Procedure" (48 trials), "Biological" (35 trials) and "Radiation" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Cyclophosphamide" (35 trials), "Vincristine Sulfate" (31 trials), "Doxorubicin Hydrochloride" (25 trials) and "Etoposide" (24 trials). Other intervention names were less common.

The vast majority of trials in "Legacy Emanuel Children's Hospital" are 132 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Legacy Emanuel Children's Hospital". undefined are not yet recruiting, 40 are recruiting, 49 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Legacy Emanuel Children's Hospital, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Legacy Emanuel Children's Hospital, 4 "Phase 1" clinical trials were conducted, 45 "Phase 2" clinical trials and 56 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".